It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Aims/hypothesis
Endoplasmic reticulum (ER) stress and beta cell dedifferentiation both play leading roles in impaired insulin secretion in overt type 2 diabetes. Whether and how these factors are related in the natural history of the disease remains, however, unclear.
Methods
In this study, we analysed pancreas biopsies from a cohort of metabolically characterised living donors to identify defects in in situ insulin synthesis and intra-islet expression of ER stress and beta cell phenotype markers.
Results
We provide evidence that in situ altered insulin processing is closely connected to in vivo worsening of beta cell function. Further, activation of ER stress genes reflects the alteration of insulin processing in situ. Using a combination of 17 different markers, we characterised individual pancreatic islets from normal glucose tolerant, impaired glucose tolerant and type 2 diabetic participants and reconstructed disease progression.
Conclusions/interpretation
Our study suggests that increased beta cell workload is accompanied by a progressive increase in ER stress with defects in insulin synthesis and loss of beta cell identity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



















1 University of Siena, Diabetes and Metabolic Disease Unit, Department of Medicine, Surgery and Neurosciences, Siena, Italy (GRID:grid.9024.f) (ISNI:0000 0004 1757 4641); Fondazione Umberto Di Mario, c/o Toscana Life Sciences, Siena, Italy (GRID:grid.428757.b)
2 Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Endocrinologia e Diabetologia, Roma, Italy (GRID:grid.411075.6) (ISNI:0000 0004 1760 4193); Università Cattolica del Sacro Cuore, Dipartimento di Medicina e Chirurgia Traslazionale, Roma, Italy (GRID:grid.8142.f) (ISNI:0000 0001 0941 3192)
3 Università Cattolica del Sacro Cuore, Dipartimento di Medicina e Chirurgia Traslazionale, Roma, Italy (GRID:grid.8142.f) (ISNI:0000 0001 0941 3192); Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Pancreatic surgery unit, Pancreatic Advanced Research Center (CRMPG), Roma, Italy (GRID:grid.411075.6) (ISNI:0000 0004 1760 4193)
4 Institute of Neuroscience, National Research Council, Padova, Italy (GRID:grid.418879.b) (ISNI:0000 0004 1758 9800)
5 Università Cattolica del Sacro Cuore, Dipartimento di Medicina e Chirurgia Traslazionale, Roma, Italy (GRID:grid.8142.f) (ISNI:0000 0001 0941 3192); Fondazione Policlinico Universitario A. Gemelli IRCCS, U.O.S. Terapia Conservativa della Malattia Renale Cronica, Roma, Italy (GRID:grid.414603.4)
6 Università Cattolica del Sacro Cuore, Dipartimento di Medicina e Chirurgia Traslazionale, Roma, Italy (GRID:grid.8142.f) (ISNI:0000 0001 0941 3192); Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Digestive Disease Center, Roma, Italy (GRID:grid.411075.6) (ISNI:0000 0004 1760 4193)